While PubMed registers record publications, JAMA review questions the robustness of evidence; understand the current scenario of cannabis research

While the North American market invests in high-end commercial lounges, Mexico City implements regulated tolerance zones in public areas

New US rule restricts hemp derivatives and opens opportunity for South American countries to meet part of the Brazilian demand

While New York reaches the milestone of 500 legal stores, the Brazilian auxiliary cannabis market projects to move nearly R$ 1 billion in 2025

Experts analyze the scenario and highlight that the measure meets Anvisa's expectations for the Brazilian market; Analysis reveals that the new legislation does not represent prohibition, but rather a restructuring of the sector focusing on taxation and pharmaceutical control

The data reveals a cultural shift that reflects new perceptions about health, habits, and public policies

A study funded in the USA reveals that Snapchat's AI blocks responses about marijuana but provides information about alcohol and delta-8 THC, raising questions about safety and regulation

Workers in Michigan and Pennsylvania lead the longest work stoppages in the history of the sector, exposing growing labor tensions

Sean Spicer stated that federal cannabis legalization will not happen under the Trump administration, despite signs of support for specific reforms during the campaign

New FDA study shows that CBD can cause liver damage in some people. Understand the risks, symptoms, and what to do to use it safely

The United Nations Commission on Narcotic Drugs (CND) approved, by a qualified majority, the recommendation to include hexahydrocannabinol (HHC) in Schedule II of the 1971 Convention on Psychotropic Substances

Research debunks the relationship between prenatal exposure to the plant's derivatives and autism diagnosis

Study indicates possible increases in cancer chances but acknowledges limitations in the research conducted

As interest in the therapeutic and medical potential of psychedelics in general continues to grow, a laboratory contracted by the Nida Addiction Treatment Discovery program will conduct preclinical tests to determine the pharmacological properties

The conversation focused on key areas of interest for hemp companies, especially regarding testing laboratories and certification

The percentage of women in senior positions in the cannabis sector is still much higher than the national average for all businesses.

Most common symptoms of the disease called VAPI are shortness of breath, dry cough, fatigue, chest pain, and coughing up blood

Episode addresses the update of RDC 660, international certification, and challenges to expand access to treatments with different cannabinoids in Brazil.

USDA study identified compounds in hemp roots with activity against pediatric cancer cells, pointing to new possibilities for scientific research

The debate brought together experts in law, science, and ethics to discuss evidence, risks, and regulatory models for the therapeutic use of these substances